from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1105/-

LFCtreatmentdescriptionclass of inhibitor

0.283

Amikacinug/mL Amikacintranslation

-0.036

Cap5-10ug/mL Capreomycintranslation

0.241

Rox10-50 ug/mL Roxithromycintranslation

0.079

SM2-5 ug/mL Streptomycintranslation

1.261

Tet5-10 ug/mL Tetracyclinetranslation

0.250

Rif0.2-5ug/mL Rifampicintranscription

0.283

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.513

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.385

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.191

CPZ10-50 ug/mL Chlorpromazinerespiration

1.206

Clofazimine10-13 ug/mL Clofaziminerespiration

0.351

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.970

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.590

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.847

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.109

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.128

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.279

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.378

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.651

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.944

KCN5-20 ug/mL Potassium cyaniderespiration

0.201

NaN30.2-2 mM Sodium aziderespiration

-0.890

Nigericin50 uM Nigericinrespiration

0.347

TRC10-150 ug/mL Triclosanrespiration

1.444

TRZ10-25 ug/mL Thioridazinerespiration

0.260

Valinomycin0.5-10 uM Valinomycinrespiration

-0.381

ZnSO42 mM ZnSO4respiration

-1.147

menadione6-10 ug/mL Menadionerespiration

-0.192

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.735

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.386

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.979

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.427

NRP_1Non-replicating persistence stage 1dosRassociated

-0.207

Amp0.2mg/mL AmpicillincellWall

-0.020

Cephalexin20-100 ug/mL CephalexincellWall

-0.675

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.533

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.231

EMB10-20 ug/mL EthambutolcellWall

0.143

Eta12-40 ug/mL EthionamidecellWall

0.178

INH0.2-0.4 ug/mL IsoniazidcellWall

0.055

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.632

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.338

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.869

BZA0.12 mg/mL BenzamidearomaticAmides

-0.416

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.145

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.172

H2O24 mM hydrogen peroxideDNAdamaging

-0.186

Levo10 ug/mL LevofloxacinDNAdamaging

-0.214

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.928

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.067

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.034

UVUV-irradiationDNAdamaging

1.494

ARP41-4 ug/mL Antitubercular compound ARP4?

0.243

Antimycin12.5-50 ug/mL Antimycin A?

-0.527

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.795

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.927

PA8240.2-2 ug/mL PA-824?

-0.037

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.168

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.412

Verapamil50 uM Verapamil?

-0.576

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.318

methoxatin10-20 ug/mL Methoxatin?